Dr. Colón is CEO of InCarda Therapeutics, a senior advisor (and formerly partner) at New Science Ventures and serves on the board of directors of ProterixBio, Paradigm Diagnostics, PerceptiMed and Cocoon Biotech. She is also a member of the Advisory Board of the Miller Center for Social Entrepreneurship at Santa Clara University. Previously, she was founding President of the Industrial Products Division at Intrexon Corporation and held various leadership roles at Gilead Sciences. Prior to Gilead, she was VP, Corporate Planning at Affymetrix, where she also served as COO for the International Genomics Consortium, a non-profit medical research organization focused on cancer genomics. Earlier in her career she was a consultant with McKinsey and an engineer with Merck & Co. in France and in Rahway, NJ. Dr. Colón received her Ph.D. from the Massachusetts Institute of Technology and a B.S. degree from the University of Pennsylvania, both in chemical engineering.